some innovation that might not otherwise occur. And that’s another way we differ from traditional journalism—we see ourselves as an active part of the community we report on, not just passive observers. We want to help lead the discussion about the most important issues in Northwest innovation. That, plus our authoritative voice on the specific technologies and businesses that leaders need to know about in today’s ultracompetitive climate, are what we think sets us apart from the media pack.
Of course, we are still in the early stages of this venture, but it is the most exhilarating ride of our professional lives. We are honored to be supported by a number of underwriters, venture members, and partners, including Alexandria Real Estate Equities, AT&T Wireless, EMC, the Science & Technology Directorate of the U.S. Department of Homeland Security, Fenwick & West, Cooley Godward Kronish, ARCH Venture Partners, Polaris Venture Partners, the Washington Technology Industry Association, the Technology Alliance, the Alliance of Angels, and the Washington Biotechnology and Biomedical Association.
And thank you, readers, for joining us on the journey. We enjoy hearing your feedback, at our events and other in-person meetings, as well as through your comments on the site, as you engage us in often fascinating conversations and help us do our jobs better. We make our personal contacts available on every story we write. And you can always reach us at [email protected], or send us story ideas to [email protected]. We hope you’ll keep us on our toes, and stick around for many more anniversaries to come.
P.S. No birthday celebration would be complete without a quick rundown of our favorite hits, of course. So we’ve selected six Seattle stories from 2009 that we think best encapsulate Xconomy’s brand of journalism, in no particular order. Enjoy!
The Rise of Seattle’s High-Tech Cluster, As Told By Madrona’s Tom Alberg
From MIT Blackjack Team to Amazon Acquisition: The Lexcycle Story
How Not to Work for The Man: Jonathan Sposato on Life at Picnik, Microsoft, and Google
Dendreon Saga Heads Toward Climax, as Cancer Drug Aims to Prove It Prolongs Lives
The Washington Cleantech Cluster: The A-to-Z List of Alternative Energy Players
Cell Therapeutics Teeters on the Brink as Cash Runs Out on Promising Cancer Drugs